Skip to main content

Day: April 16, 2021

ARHT Media Announces Fiscal Year 2020 Results

TORONTO, April 16, 2021 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or “the Company”) (TSXV:ART), the global leader in the development, production and distribution of high-quality, low latency hologram and digital content, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2020. 2020 Financial UpdateRevenues for Fiscal Year 2020 were $2.21M as compared to $3.28M for Fiscal Year 2019; Net loss for 2020 was $3.77M as compared to $3.69M for the same period in 2019; Cash and cash equivalents were $486k at Dec 31, 2020 as compared to $213k at Dec 31, 2019.2020 Business UpdatesThe Company completed a number of reseller and strategic partner agreements, which resulted in sales that include a major international defense contractor, AT&T, China Unicom, Junior...

Continue reading

Rowland Howe Appointed President of Red Moon

ST. JOHN’S, Newfoundland and Labrador, April 16, 2021 (GLOBE NEWSWIRE) — Red Moon Resources Inc. (the “Company” or “Red Moon” – TSXV: RMK) announces that Mr. Rowland Howe has been appointed President of the Company, effective immediately, with Mr. Howe focusing on guiding the Great Atlantic Salt Project through an exciting transformative period for this asset and the North American salt market in general. Mr. Howe is highly regarded in the global salt industry and was manager at Compass Minerals’ Goderich mine in southern Ontario from 1996 to 2010 as that operation grew into the largest underground salt mine in the world. He continued with Compass for another six years in a strategic engineering role, delivering key projects across the company’s divisions, before retiring in 2016. Mr. Patrick Laracy, Red Moon CEO, commented:...

Continue reading

InterDigital Announces Date for First Quarter 2021 Financial Results

WILMINGTON, Del., April 16, 2021 (GLOBE NEWSWIRE) — InterDigital, Inc. (NASDAQ:IDCC), a mobile and video technology research and development company, today announced that the company will release its first quarter 2021 financial results before market open on Thursday, May 6, 2021. InterDigital executives will host a conference call that same day at 10:00 a.m. Eastern Time (ET) to discuss the company’s financial performance and other company matters. For a live Internet webcast of the conference call, visit www.interdigital.com and click on the link to the live webcast on the Investors page. The company encourages participants to take advantage of the Internet option. For telephone access to the conference, call (800) 367-2403 within the United States or +1 (334) 777-6978 from outside the United States. Please call by 9:50...

Continue reading

goeasy Ltd. Announces Closing of $172.5 Million Bought Deal Equity Offering of Subscription Receipts

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MISSISSAUGA, Ontario, April 16, 2021 (GLOBE NEWSWIRE) — goeasy Ltd. (TSX: GSY), (“goeasy” or the “Company”), a leading full-service provider of goods and alternative financial services, announced today that it has closed its previously announced bought deal equity offering of 1,404,265 subscription receipts of the Company (“Subscription Receipts”) (including 183,165 Subscription Receipts issued pursuant to the exercise in full by the syndicate of underwriters led by BMO Capital Markets of the over-allotment option granted by the Company), at a price of $122.85 per Subscription Receipt, for gross aggregate proceeds of $172.5 million (the “Offering”). The Subscription Receipts issued pursuant to the Offering will commence trading on the...

Continue reading

Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc.

WEST LAFAYETTE, Ind., April 16, 2021 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of non-clinical and analytical contract research services, today announced that the Company has entered into an agreement and plan of merger with Bolder BioPATH, Inc. (“Bolder BioPATH”), a contract pharmacology and pathology company specializing in in vivo models of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diseases of the central nervous system and other autoimmune, inflammation, and pain models. “Bolder BioPATH adds depth to our existing pharmacology enterprise, allowing us to extend our market reach in early-stage drug discovery, and brings us significant new cross-selling opportunities,” said Robert Leasure, Jr., Inotiv’s President and Chief Executive Officer....

Continue reading

ME2C® Environmental to Present at Planet MicroCap Showcase

CORSICANA, TX, April 16, 2021 (GLOBE NEWSWIRE) — Midwest Energy Emissions Corp. (OTCQB: MEEC) (“ME2C Environmental” or the “Company”), a leading environmental technologies firm, today announced that management will present at the Planet MicroCap Showcase, taking place virtually April 20-22, 2021. The Planet MicroCap Showcase virtual event brings together the most promising companies for three days of company presentations, one-on-one meetings and educational panels. Richard MacPherson, President and Chief Executive Officer of ME2C Environmental, is scheduled to participate in one-on-one meetings with investors throughout the event and will host a virtual presentation as follows: The Planet MicroCap ShowcaseDate: Thursday, April 22, 2021Time: 2:00 p.m. Eastern timeWebcast: https://www.webcaster4.com/Webcast/Page/2059/40841 A...

Continue reading

QCI to Present at Zooming with LD Micro on April 20, 2021

LEESBURG, Va., April 16, 2021 (GLOBE NEWSWIRE) — Quantum Computing Inc. (OTCQB: QUBT) (QCI), a leader in bridging the power of classical and quantum computing, has been invited to present at the Zooming with LD Micro virtual event on April 20, 2021. QCI is the first public pure-play company that accelerates the value of quantum computing for real-world business solutions. Robert Liscouski, QCI’s president and CEO, will participate in one-on-one meetings with investors and analysts during the conference and is scheduled to present on Tuesday, April 20 at 11:00 a.m. EDT (8:00 a.m. PDT). Liscouski will discuss the recent launch of QCI’s Qatalyst™ quantum application accelerator as a software-as-a-service (SaaS) on Amazon Web Services (AWS). The SaaS eases cloud access to major quantum computers via Amazon Braket, including D-Wave,...

Continue reading

Takeover Industries Introduces its Veteran Sales Dream Team

ATLANTA, April 16, 2021 (GLOBE NEWSWIRE) — Labor SMART, Inc. (LTNC) (the “Company”), announced that its recently acquired subsidiary, Takeover Industries Inc., has officially assembled its National Sales Dream Team. Takeover’s new National Sales team consists of three accomplished industry veterans with the extensive knowledge, relationships and experience to manage all facets of sales and distribution from coast to coast. Joe Pavlik, Labor Smart Inc. CEO & Takeover Industries President and Chief Science Officer, commented, “We’re ready to erupt and disrupt, as each member of this team has earned respect and helped major beverage brands achieve success from their commitment and performance over time. Bringing this team on is critical to a successful official launch of NXT LVL Hydrogen Water and our additional upcoming products.” Takeover...

Continue reading

Adverum Biotechnologies to Present New Data from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at ARVO 2021 

— Adverum to host webcast with key opinion leaders on Sunday, May 2, 2021 at 7:00 AM PT —  REDWOOD CITY, Calif., April 16, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the presentation of additional clinical data for Cohorts 1-4 in the OPTIC clinical trial of ADVM-022 intravitreal (IVT) injection gene therapy in wet age-related macular degeneration (wet AMD) during the Association for Research in Vision and Ophthalmology (ARVO) 2021 Virtual Meeting. Preclinical data on ADVM-062, a novel IVT gene therapy that also utilizes Adverum’s proprietary vector capsid AAV.7m8, in blue cone monochromacy will also be presented. Presentation Title: Phase 1 Study of Intravitreal Gene Therapy with...

Continue reading

SANUWAVE Health to Present Energy First Solutions at Upcoming Wound Care Industry Conferences

SUWANEE, GA, April 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, announced today that the Company will be participating in a number of leading wound care industry conferences – both virtual and in-person – where it will highlight the clinical merits of its “Energy First” protocols and showcase how its end-to-end portfolio of non-invasive and biologic-response therapeutic solutions address the entire wound care continuum. SANUWAVE is currently scheduled to participate in the following industry events: “We are excited to share SANUWAVE’s new brands with the country’s leading wound care specialists at upcoming industry conferences, starting with the SuperBones event on April 18th, where we will discuss the coding, billing and reimbursement...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.